Bridgeway Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $1.64 Million - $2.3 Million	-13,600 Reduced 49.1%	14,100 $2.06 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $3.52 Million - $4.82 Million	27,700 New	27,700 $4.52 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $4.77 Million - $5.82 Million	-54,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $6.26 Million - $8.02 Million	54,000 New	54,000 $6.43 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.